For prevention of atherosclerotic events in patients with: History of recent myocardial infarction (within a few days until less than 35 days from occurrence), recent ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q- wave MI) including patients who are managed medically with percutaneous coronary intervention (with or without stent) or coronary artery bypass graft (CABG). It is given prophylactically as an alternative to aspirin in patients at risk of thromboembolic disorders such as myocardial infarction, peripheral arterial disease and stroke.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

Recent MI or Stroke, or established peripheral arterial disease: Recommended Dose: Orally, 75 mg once daily with or without food. prophylaxis of thromboembolic event: Usual dose: Orally, 75 mg once daily. Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI): Initiate a single 300 mg loading dose and then continue at 75 mg once daily in combination with aspirin. A higher bleeding risk was associated with combined use of clopidogrel and aspirin. It is recommended that physicians monitor their patients through clinical and laboratory evaluation. Or, as prescribed by a physician.

May be taken with or without food.